LEXX — Lexaria Bioscience Corp.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1348362 ·
Last close
$4.18
Market Cap
$8.81M
52W High
$21.60
52W Low
$2.43
ADV30
45,369
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
May 2026 0 0 -1,993,804 -1,991,202 4,781,331 3,475,003 437,091
Feb 2026 20,000 20,000 -1,451,903 -1,449,979 6,487,303 5,128,141 276,997
Nov 2025 0 0 -1,573,631 -1,595,007 6,050,807 4,281,233 1,527,353
Aug 2025 174,000 174,000 -2,688,597 -2,695,838 4,175,121 1,802,123 1,572,366

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,425,488
Investing CF
$-243,975
Financing CF
$6,518,105
CapEx
$-101,872
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.30
As of
2026-10-18

Balance + Analyst (yfinance extras)

Retained Earnings
$-68,496,801
Inventory
—
Receivables
$48,998
ST Investments
$142,103
EBIT TTM
$-7,707,935
Pretax Income TTM
$-7,736,041
Interest Exp TTM
—
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$194,000
EBITDA
$-7,417,538
Free Cash Flow
$-4,688,228
Enterprise Value
$2,636,051
Total Cash
$3,617,106
Total Debt
$86,714
Shares Out
2,106,487
Trailing EPS
$-5.10
Book Value
$2.87
ROE
-162.8%
ROA
-81.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Aug 2025 705,923 -11,880,737 -11,901,841 4,175,121 1,572,366 2,989,697 -10,450,387
Aug 2024 464,278 -5,753,130 -5,795,345 8,867,789 1,208,738 8,036,400 -4,959,003
Aug 2023 226,208 -6,534,022 -6,664,899 3,083,986 403,908 3,044,118 -5,881,237
Aug 2022 255,397 -6,619,039 -7,269,324 7,833,927 201,437 7,948,904 -4,879,339

TTM Snapshot

Revenues TTM
$194,000
NetIncome TTM
$-7,732,026
OpCashFlow TTM
—
Assets (Latest)
$4,781,331
Forward EPS
$-0.39

Peers — same industry

TickerNameMarket CapLastDaily %
BFRI Biofrontera Inc. $8.81M $0.59 —
PHIO Phio Pharmaceuticals Corp. $8.57M $0.72 —
DARE Dare Bioscience, Inc. $8.44M $0.43 —
CALC CalciMedica, Inc. $8.41M $1.22 —
CLRB Cellectar Biosciences, Inc. $9.24M $0.92 —

News headlines (Yahoo Finance, 1h cache)

LEXX: New Pharmaceutical Agreement
2026-11-09 08:00 · Yahoo
Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
2026-11-04 14:00 · Yahoo
Lexaria Celebrates its 70th Patent Award
2026-10-28 13:10 · Yahoo
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
2026-10-21 13:25 · Yahoo
Lexaria Announces Results from Animal Study GLP-1-A26-1
2026-10-15 13:10 · Yahoo
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
2026-10-06 13:10 · Yahoo
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
2026-09-08 12:00 · Yahoo
LEXX: Introducing DehydraTECH 3.0
2026-09-08 10:15 · Yahoo
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-04 13:20 · Yahoo
Lexaria Receives USD$2.6 Million Tax Rebate Payment
2026-09-01 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.